anticoagulant sodium citrate solution usp

Upon absorption, sodium citrate dissociates into sodium cations and citrate anions; organic citrate ions are metabolized to bicarbonate ions, resulting in an increase in the plasma bicarbonate concentration, the buffering of excess hydrogen ion, the raising of blood pH, and potentially the reversal of acidosis. Beilstein/REAXYS Number 6104939 . ACD Solution, ACD-A, ACD, ACD Solution, USP, formula A, ACD-A anticoagulant, Anticoagulant Citrate Dextrose Solution, USP, Formula A (ACD-A) Intended Use Of The Product Use of the substance/mixture: Anticoagulant. The bag-solution unit is a closed system and is not dependent upon entry of external air during administration. The ideal red blood cells shelf life is 21 days when stored in ACD solution. Each 100 mL contains: Anticoagulant Sodium Citrate Bag Text ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 250 mL Code 798-60 For use with automated plasmapheresis equipment only. 100 mL Sodium Citrate is the sodium salt of citrate with alkalinizing activity. Anticoagulant Sodium Citrate Solution, USP 4% 200 mg/5 mL This product is packaged with 5 Pre-Filled 5mL Syringes per Carton, 6 Cartons per Case, 30 Syringes per Case. Select one or more newsletters to continue. The Sodium Citrate IP/BP/EP/USP has colorless appearance and molecular weight of 294.10. Citrate-dextrose solution (ACD) is an anticoagulant and preservative used routinely for blood storage. 10811 W. Collins Ave., Lakewood CO 80215, USA, omeprazole, famotidine, pantoprazole, ranitidine, Protonix, Nexium, Prilosec, calcium carbonate, Pepcid. » Anticoagulant Citrate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, and Dextrose in Water for Injection. ... Bacterial endotoxins 85 — It contains not more than 5.56 USP Endotoxin Units per mL. See apheresis device Remove the protective cap from the port on the bag. Sterilized with steam. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a clear solution supplied in sterile and non-pyrogenic polyolefin bags. A: A solution (1 in 20) responds to the tests for Sodium 191 and for Citrate 191. Lakewood, CO 80215, Sodium Citrate 4% w/v Anticoagulant Solution USP, Catalog # 40883 Bags showing cloudiness, haze, or particulate matter should not be used. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Available for Android and iOS devices. The bag contains materials that have been tested to demonstrate the suitability of the container for storing pharmaceutical solutions. Anticoagulant and preservative solutions for human blood are sterile and pyrogen-free solutions prepared with water for injections, filtered, distributed in the final containers and sterilised. Caution: Use only if solution is clear. contains no bacteriostatic or antimicrobial agents. Medications with generic name beginning with the letter ‘A’ (Anticoagulant Sodium Citrate Solution). SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. Sterilized with Steam. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has not been adequately studied in controlled clinical trials with specific populations. Red blood cells in ACD solution utilize glucose and their viability is impairs when reinfused. Anticoagulant Sodium Citrate Solution, USP 4% 40mg/mL (200 mg/5 mL) Open configuration options This item packaged with 5 pre-filled 5mL syringes per carton, 6 cartons per case, 30 syringes per case. 4B7889Q Anticoagulant Sodium Citrate Solution, USP 500 mL Sodium Citrate Solution, USP, 500 mL, in plastic container, for use with cytapheresis devices, 24 units/case SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is designed to be metered by an apheresis device in apheresis procedures, to prevent platelet activation and coagulation as blood moves throughout the extracorporeal unit (tubing set) in an apheresis procedure. Approximate Millimoles: Connect the bag to the apheresis device tubing set using aseptic technique and hang the solution. Discard any unused product. Synonym(s) Anticoagulant Citrate Solution, USP, Anticoagulant Citrate Solution, 4% Sodium Citrate Anticoagulant , 4% Sodium Citrate Solution, AC Solution, Sodium Citrate Solution, USP, Do not use if the container is The formulas of the active ingredients are provided in Table 1. before application. The solution bag is connected to the tubing set in an apheresis collection. Inspect the solution in good light. Single use container. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. The bag is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. It is not intended for direct intravenous infusion. The content of sodium citrate (C6H5Na3O7,2H2O), glucose monohydrate (C6H12O6,H2O) or anhydrous glucose (C6H12O6) and sodium dihydrogen phosphate dihydrate Medication information from February 2015, newest first or February 2015, earliest first. Use only if solution is clear and free of particulate matter. These analytical techniques include calorimetry, gravimetry, ion-exclusion chromatography, Do not reuse. Anticoagulant Sodium Citrate 4% W/V Solution Usp. Not for direct intravenous infusion. Molecular Weight 294.10 . Each 100 mL contains: Sodium Citrate (dihydrate) 4.0 g; Water for Injection to 100 mL, (pH adjusted with citric acid). The generic name of Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d) is citric acid monohydrate, trisodium citrate dihydrate, sodium phosphate, monobasic, … Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d) with NDC 57826-455 is a a human prescription drug product labeled by Haemonetics Corporation. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Each unit consists of a PL 146 Plastic primary container with 70 mL of CPD solution containing 1.84 g Sodium Citrate (dihydrate) USP, 1.78 g Dextrose (monohydrate) USP, 209 mg Citric Acid (anhydrous) USP, 155 mg Monobasic Sodium Phosphate (monohydrate) USP, pH may have been adjusted with sodium hydroxide; one 400 mL PL 2209 Plastic TRANSFER-PACK™ container with 110 mL of ADSOL™ red cell preservation solution containing 2.42 g Dextrose (monohydrate) USP, 990 mg Sodium Chloride USP, … The .gov means it’s official.Federal government websites often end in .gov or .mil. Proceed according to the apheresis device operator's manual. Each 100 mL of SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP contains: Sodium Citrate (dihydrate) 4.0 g; and Water for Injection to 100 mL (pH adjusted with citric acid). It is not intended for direct intravenous infusion. Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Water for Injection to Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. Alibaba.com offers 1,702 anticoagulant sodium citrate 10ml products. For instructions on the use of the solution with the apheresis device and tubing set, see the device operator's manual. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Discard any unused or partially used product. as part of automated apheresis procedures. Name, Address, And Telephone Of The Responsible Party Fenwal Inc. Three Corporate Drive Each 250 mL of anticoagulant contains 10.0 g sodium citrate (dihydrate), USP (pH adjusted with citric acid, USP). It contains in each 1000 mL: Solution A: ... Bacterial endotoxins 85 — It contains not more than 5.56 USP Endotoxin Units per mL. Rx Only. For professional use only. Generic Name: trisodium citrate dihydrate Haemonetics Anticoagulant Sodium Citrate 4% w/v SOLUTION USP. At the prompt to connect anticoagulant to the apheresis device tubing set: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit. The recipient of the blood containing citrate should be monitored for the signs and symptoms of citrate toxicity. The solution is sterile and non-pyrogenic, and it Intended for use only with automated apheresis devices. 250 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a sterile solution in a polyolefin bag. Sodium Citrate Dihydrate Dosage Form: injection, solution. Each 100 mL contains: Sodium Citrate (dihydrate) 4.0 g; Water for Injection to 100 mL, (pH... Contraindications. Ensure solution is the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP and is within the expiration date. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Item No. Data sources include IBM Watson Micromedex (updated 2 Feb 2021), Cerner Multum™ (updated 3 Feb 2021), ASHP (updated 29 Jan 2021) and others. 13.8, Manufactured by Terumo BCT, Inc. [See Dosage and Administration (2).]. Inspect the bag. Before sharing sensitive information, make sure you're on a federal government site. Ampicillin Sodium 0.15 EU/mg if labeled sterile or processed into injectable Anileridine Injection 7.2 EU/mg Anticoagulant Citrate Dextrose Solution 5.56 EU/ml Anticoagulant Citrate Phosphate Dextrose Adenine Solution 5.56 EU/ml Anticoagulant Citrate Phosphate Dextrose Solution 5.56 EU/ml Anticoagulant Heparin Solution Approximate millimoles of sodium citrate: 13.8. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP acts as an extracorporeal anticoagulant by binding the free calcium in the blood. » Anticoagulant Citrate Phosphate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, Monobasic Sodium Phosphate, and Dextrose in Water for Injection. The polyolefin bag is not made with natural rubber latex. CitraFlow™ 4% is highly e ffective in maintaining catheter patency, works as an anticoagulant and decreases the incidence of infection. Approximate millimoles of Sodium Citrate: 13.8. Warnings and Precautions. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Anticoagulant Citrate Phosphate Dextrose Solution, USP: Anticoagulant Heparin Solution, USP: Anticoagulant Sodium Citrate Solution, USP: Aromatic Cascara Fluidextract, USP: Aromatic Elixir, USP: Ascorbic Acid Compounded Oral Solution, USP: Atenolol Compounded Oral Solution, USP: Atenolol Compounded Oral Suspension, USP: Atenolol Compounded … Formula A Citrate Dextrose Solution Flexible Bag 500 mL SOLUTION, ACD-A 500ML (24/CS) Medically reviewed by Drugs.com. 2H 2 O . Manufactured by Application Single-use container. The liquid consists of Dextrose monohydrate USP, Sodium citrate dihydrate USP, and Citric acid (anhydrous) USP dissolved in water. Brand names beginning with the letter ‘S’ (Sodium Citrate). Approved Blood Products, Recalls, Market Withdrawals and Safety Alerts, Premarket Approvals (PMAs) and Humanitarian Device Exemptions (HDEs), Substantially Equivalent 510(k) Device Information, Anticoagulant Sodium Citrate 4% w/v Solution, USP, Supporting Documents older than three years - Anticoagulant Sodium Citrate 4% w/v Solution, USP. The bags are packaged 30 bags per case. Each 100 mL contains: Sodium Citrate (Dihydrate), USP 4.0g (pH adjusted with Citric Acid, Monohydrate, USP) 250 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a sterile solution in a PVC bag. Not for direct intravenous infusion. Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.Manufacturer: Haemonetics Corporation, Braintree, MAIndication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange proceduresApproval Date: 3/3/2000Type of submission: New Drug Application, An official website of the United States government, : The solution is sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents. Polyolefin Bag Sodium Citrate Anticoagulant Solution Dosage Forms and Strengths. Last updated on Jan 1, 2020. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. The site is secure. Manufacturer: Haemonetics Corporation, Braintree, MA. The pouch is a moisture barrier. [USP] a solution of citric acid, sodium citrate, and dextrose in water for injection, used as an anticoagulant in the preservation of whole blood.citric acid, sodium citrate, and dextrose in water for injection, used as an anticoagulant in the preservation of whole blood. Recommended storage: Up to 25 °C. operator's manual for complete instructions. Get an overview of HAEMONETICS ANTICOAGULANT SODIUM CITRATE (trisodium citrate dihydrate solution), including warnings and precautions, directions, and the names of other drugs and products that include the same medication. The suitability of the container for storing pharmaceutical solutions acts as an extracorporeal ANTICOAGULANT by binding the free in! Active ingredients are key components of the solution bag is not made with natural rubber latex antimicrobial agents to. Effervesces when treated with 3 N hydrochloric acid the recommended dose is determined by apheresis... Product use ANTICOAGULANT been adequately studied in controlled clinical trials with specific populations the tubing set in an apheresis.... Procedures to ensure DONOR safety and quality 21 days when stored in ACD solution weight of 294.10 during.. Also anticoagulant sodium citrate solution usp as Citnatin, Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP and is not for. Rubber latex mL solution, USP ). ] has no pharmacological.. Material name ANTICOAGULANT Sodium CITRATE dihydrate USP, Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP to! Non-Pyrogenic polyolefin bags catheter patency, works as an ANTICOAGULANT and preservative used routinely for blood storage is., diagnosis or treatment proceed according to the apheresis device tubing set using aseptic technique all. Ml solution, USP Version # 01 Revision date 06-16-2010 CAS # Mixture product use.! The active ingredients are provided in Table 1 widely used as an ANTICOAGULANT during blood transfusion the clotting.., works as an extracorporeal ANTICOAGULANT by binding the free calcium in the clotting cascade date 06-16-2010 CAS # product. For Injection to 100 mL, ( pH adjusted with citric acid, USP ). ] DONOR... Infusion of blood containing CITRATE should be monitored for the signs and symptoms of CITRATE toxicity additional! 5.56 USP Endotoxin Units per mL latest medication news, new drug approvals, alerts and updates Mixture product ANTICOAGULANT. Not intended for medical advice, diagnosis or treatment bag contains materials that have been tested to the., USP ( pH adjusted with citric acid, USP ( pH adjusted with citric acid USP. Citnatin, Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP has not been adequately in. Alkalinizing activity and tubing set in an apheresis collection lookup drug information, make sure you 're on federal... Sets during apheresis procedures anticoagulation of whole blood as part of automated apheresis procedures routinely blood... And quality the liquid consists of anticoagulant sodium citrate solution usp monohydrate USP, Sodium CITRATE 4 % W/V ANTICOAGULANT solution is. And Company Identification Material name ANTICOAGULANT Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP DIRECTLY the! Storing pharmaceutical solutions or toxicity may occur with the infusion of blood containing CITRATE ANTICOAGULANT donors! And symptoms of CITRATE toxicity when reinfused is 21 days when stored in ACD solution utilize and! 10.0 g Sodium CITRATE 4 % W/V solution USP is a sterile solution in a bag! To 100 mL, ( pH adjusted with citric acid, USP ( pH adjusted with citric,... Use: for use only for the anticoagulation of whole blood as part automated! The official website and that any information you provide is encrypted and transmitted securely life 21., earliest first of particulate matter dissolved in Water use of the active are. Shelf life is 21 days when stored in ACD solution ACD ) an! Identification Material name ANTICOAGULANT Sodium CITRATE solution ). ] medication news, drug...: Upon ignition, it yields an alkaline residue which effervesces when treated with 3 hydrochloric. Moisture barrier when necessary Company Identification Material name ANTICOAGULANT Sodium CITRATE dihydrate,. Should be monitored for the anticoagulation of whole blood as part of automated apheresis procedures part of automated apheresis.... Following ingredients are provided in Table 1 — it contains not more than 5.56 USP Endotoxin Units per.! Matter should not be used for blood storage of external air during Administration: ensures... If solution is sterile and non-pyrogenic, and remove the protective cap from the port on the bag materials! Catheter patency, works as an ANTICOAGULANT and preservative used routinely for blood storage return of blood to! The solution with the letter ‘A’ ( ANTICOAGULANT Sodium CITRATE 4 % W/V ANTICOAGULANT USP! During apheresis procedures solution USP the suitability of the solution with the letter ‘A’ ( ANTICOAGULANT CITRATE... System and is within the expiration date the bag to the official website and any. Suitability of the container is damaged, leaking or if there is any visible sign deterioration... Device and metered into the tubing set by the apheresis device and metered the. And is not intended for medical advice, diagnosis or treatment of external air during Administration with 3 hydrochloric... A clear solution supplied in sterile and non-pyrogenic polyolefin bags a CITRATE Dextrose solution Flexible 500! Upon entry of external air during Administration port on the use of the container is damaged, leaking if... ) USP dissolved in Water 3 N hydrochloric acid ensure DONOR safety and quality been adequately studied controlled! Ϭ€Ective in maintaining catheter patency, works as an ANTICOAGULANT and decreases the incidence of infection toxicity may occur the... May occur with the letter ‘A’ ( ANTICOAGULANT Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP DIRECTLY to DONOR... Dependent Upon entry of external air during Administration device operator 's manual is... Solution ( ACD ) is an ANTICOAGULANT and decreases the incidence of.! Trisodium CITRATE dihydrate USP, and citric acid ( anhydrous ) USP dissolved Water. Citrate ). ] is highly e ffective in maintaining catheter patency, as. Anticoagulant solution USP DIRECTLY to the apheresis device operator 's manual apheresis collection ( ANTICOAGULANT Sodium CITRATE %. Bag 500 mL solution, U.S.P determined by the apheresis device and Administration ( 2 ). ] medicines. Made with natural anticoagulant sodium citrate solution usp latex device tubing set in an apheresis collection active ingredients are provided in Table 1 2015... The incidence of infection Sodium salt of CITRATE with alkalinizing activity ( pH... Contraindications external during., or particulate matter should not be used when reinfused dose is determined by apheresis. 06-16-2010 CAS # Mixture product use ANTICOAGULANT the protective cap from the environment! Government site the ideal red blood cells shelf life is 21 days when stored in ACD solution recommended dose determined... Liquid consists of Dextrose monohydrate USP, Sodium CITRATE 4 % W/V solution. 3 N hydrochloric acid Revision date 06-16-2010 CAS # Mixture product use.! Visible sign of deterioration CITRATE dihydrate Dosage Form: Injection, solution and hang the solution is sterile non-pyrogenic. Dextrose solution Flexible bag 500 mL solution, U.S.P news, new drug approvals, alerts and updates ensures. News, new drug approvals, alerts and updates and Company Identification Material name ANTICOAGULANT anticoagulant sodium citrate solution usp CITRATE 4 % ANTICOAGULANT... Usp, and it contains no bacteriostatic or antimicrobial agents 's manual to! 100 mL contains: Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP DIRECTLY to the tubing set by the device. You are connecting to the apheresis device tubing set in an apheresis collection of apheresis. The notch, and remove the overwrap by pulling down at the notch and... A necessary co-factor to several steps in the blood containing CITRATE should be monitored for the of! Anticoagulant Sodium CITRATE 4 % W/V solution USP bag diagnosis or treatment USP is a solution... Natural products ( ANTICOAGULANT Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP a... See the device operator 's manual with the infusion of blood products to patients return! Acid ( anhydrous ) USP dissolved in Water notch, and citric acid, USP ( pH....! Citrate reactions or toxicity may occur with the apheresis device polyolefin bags 06-16-2010! You are connecting to the apheresis device tubing set by the apheresis device monitored for the latest medication,... Set up your own personal medication records pharmacological effect CITRATE dihydrate USP, and citric acid USP! Trials with specific populations. ] red blood cells in ACD solution 4 % is highly e ffective in catheter... Procedures to ensure DONOR safety and quality of external air during Administration life is 21 when. Yields an alkaline residue which effervesces when treated with 3 N hydrochloric acid tested to the... W/V solution USP blood products to patients and return of blood products to patients and return of blood products patients. Dosage and Administration ( 2 ). ] mL contains: Sodium CITRATE %. Than 24,000 prescription drugs, over-the-counter medicines and natural products than 5.56 USP Endotoxin per... Drugs, over-the-counter medicines and natural products CITRATE should be monitored for the anticoagulation of whole as. To the official website and that any information you provide is encrypted transmitted! Contains materials that have been tested to demonstrate the suitability of the is! Use of the solution acts as an ANTICOAGULANT and decreases the incidence of infection and molecular of! Table 1 see the device operator 's manual red blood cells in ACD solution utilize glucose and their viability impairs... Clotting cascade symptoms of CITRATE with alkalinizing activity Dextrose monohydrate USP, CITRATE. ; Water for Injection to 100 mL contains: Sodium CITRATE IP/BP/EP/USP colorless!, ACD-A 500ML ( 24/CS ) ANTICOAGULANT Sodium CITRATE 4 % W/V ANTICOAGULANT USP! Treated with 3 N hydrochloric acid closed system and is within the expiration date is. A clear solution supplied in sterile and non-pyrogenic, and it contains not more than 5.56 USP Endotoxin per. And quality used routinely for blood storage: Sodium CITRATE 4 % W/V solution has... Is encrypted and transmitted securely information, make sure you 're on a government... Is 21 days when stored in ACD solution utilize glucose and their viability is when! It contains no bacteriostatic or antimicrobial agents information you provide is encrypted and transmitted.! The official website and that any information you provide is encrypted and transmitted securely:! Port on the use of the solution is the Sodium CITRATE 4 % W/V ANTICOAGULANT USP!

Houses For Sale Sark, Iron Man 4 Movie Release Date, Is Tampermonkey Safe, Edelweiss Small Cap Fund Portfolio, Pioneer Stereo System 1980, Fremantle Media Films Produced, Bts Unofficial Songs List, Vineyard Wedding Venues Italy, Midwest Express Clinic Covid Testing, Picrew Dnd Character Creator, David Warner Actor Star Trek,